DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer R. et al.
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.
Lancet Oncol 2015;
16: 1473-1482
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.